Last reviewed · How we verify

NCT05423405: Akupress

The Efficacy of Acupressure Therapy on Patient With Depression

Status unknown NA Last updated 21 June 2022
What this trial tests

NA trial testing Acupressure in Depressive Disorder in 150 participants. Status unknown.

Timeline
1 August 2022
Primary endpoint
1 September 2023
1 September 2024

Quick facts

Lead sponsorUniversity Psychiatric Clinics Basel
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposesupportive care
Enrollment150
Start date1 August 2022
Primary completion1 September 2023
Estimated completion1 September 2024

Drugs / interventions tested

Conditions studied

Sponsor

University Psychiatric Clinics Basel

Who can join

Adults 18 to 80, any sex, with Depressive Disorder or Depressive Disorder, Major. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A new nursing intervention with non-invasive acupressure protocol for activation of parasympathetic nervous system to reduce stress related depression symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Acupressure

Trials testing the same drug.

Other recruiting trials for Depressive Disorder

Currently open trials in the same condition.

Other University Psychiatric Clinics Basel trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05423405.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing